Within the world, the diabetes market is growing rapidly, and smart insulin pens will be one of the important solutions for treating diabetes. The intelligent insulin syringe developed by the Korean DIAMESCO Group was registered and put on the market by Roche ROCHE Pharmaceuticals in Europe. The smart syringe is jointly used by blood glucose measuring paper + mobile APP + electronic insulin syringe. The blood glucose value is detected at the same time of injecting insulin, and the blood sugar value is sent to the mobile phone end of the patient and the family doctor. The family doctor can give the patient an injection recommendation remotely. The patient can automatically adjust the injection metering.
Compared to other insulin injection pens on the market, this smart insulin pen is intelligent, automated and highly precise. First of all, it can be connected with the mobile phone APP, intelligently set up and operate, save the operation record of injecting insulin, and secondly, it can automatically inject by setting the injection amount in advance, and ensure that each injection can be accurate to 0.1U, its Operationality provides a more convenient injection for diabetics. This is a smart healthcare project that combines mobile wearables + Internet interaction + big data.